HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
Chlamydia Infections
/ diagnosis
Chlamydia trachomatis
Germany
/ epidemiology
Gonorrhea
/ diagnosis
HIV Infections
/ diagnosis
Homosexuality, Male
Humans
Male
Mycoplasma genitalium
Neisseria gonorrhoeae
Pre-Exposure Prophylaxis
/ methods
Prevalence
Prospective Studies
Sexual and Gender Minorities
Sexually Transmitted Diseases
/ diagnosis
Chlamydia
Mycoplasma genitalium, Gonorrhea
Pre-Exposure Prophylaxis
Sexually Transmitted Diseases
Syphilis
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
entrez:
8
4
2022
pubmed:
9
4
2022
medline:
12
4
2022
Statut:
ppublish
Résumé
IntroductionDespite increased use of pre-exposure prophylaxis (PrEP) in Germany, HIV infection rates are not declining and little is known about how this prevention method affects the prevalence of sexually transmitted infections (STI) among men who have sex with men (MSM).AimWe studied, in a large multicentre cohort, STI point prevalence, co-infection rates, anatomical location and influence of PrEP.MethodsThe BRAHMS study was a prospective cohort study conducted at 10 sites in seven major German cities that enrolled MSM reporting increased sexual risk behaviour. At screening visits, MSM were tested for
Identifiants
pubmed: 35393933
doi: 10.2807/1560-7917.ES.2022.27.14.2100591
pmc: PMC8991735
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Références
Sex Transm Dis. 2013 Jun;40(6):433-8
pubmed: 23677015
Sex Transm Dis. 2020 Mar;47(3):202-206
pubmed: 31880740
JAMA Netw Open. 2019 Dec 2;2(12):e1917134
pubmed: 31825501
Sex Transm Infect. 2018 Sep;94(6):457-462
pubmed: 29487172
J Clin Microbiol. 2016 Sep;54(9):2278-83
pubmed: 27307460
Infect Immun. 2012 Nov;80(11):3842-9
pubmed: 22907815
AIDS Patient Care STDS. 2012 Feb;26(2):87-94
pubmed: 22149764
AIDS Res Hum Retroviruses. 1992 Nov;8(11):1863-8
pubmed: 1489576
Emerg Infect Dis. 2019 Apr;25(4):719-727
pubmed: 30882306
Int J STD AIDS. 2019 Sep;30(10):951-959
pubmed: 31284840
Clin Infect Dis. 2021 Oct 5;73(7):e2127-e2133
pubmed: 33305785
PLoS One. 2018 Dec 3;13(12):e0208107
pubmed: 30507962
Clin Infect Dis. 2014 Mar;58(5):631-7
pubmed: 24280088
Clin Microbiol Infect. 2016 Mar;22(3):260-5
pubmed: 26686807
Sex Transm Infect. 2009 Feb;85(1):15-8
pubmed: 18842690
FEMS Immunol Med Microbiol. 2000 Jan;27(1):43-50
pubmed: 10617789
Infection. 2020 Apr;48(2):259-265
pubmed: 31993971
BMC Infect Dis. 2020 Feb 7;20(1):110
pubmed: 32033533
Pathogens. 2019 Dec 20;9(1):
pubmed: 31861901
AIDS Behav. 2019 Feb;23(2):548-555
pubmed: 30117076
Sex Transm Infect. 2020 Feb;96(1):10-18
pubmed: 31217322
J Infect Dis. 1986 Jun;153(6):1046-54
pubmed: 3701116
AIDS. 2018 Sep 24;32(15):2161-2169
pubmed: 30212403
Sex Transm Infect. 2018 Jun;94(4):255-262
pubmed: 29440466
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
J Int AIDS Soc. 2016 Dec 07;19(1):21270
pubmed: 27931519
AIDS Res Hum Retroviruses. 1993 Aug;9(8):775-80
pubmed: 8105836
Sex Transm Infect. 2021 Feb;97(1):63-68
pubmed: 32393529